127 related articles for article (PubMed ID: 15716385)
1. Site of action of beta-ligands at the human beta1-adrenoceptor.
Baker JG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1163-71. PubMed ID: 15716385
[TBL] [Abstract][Full Text] [Related]
2. Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Jun; 63(6):1312-21. PubMed ID: 12761341
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.
Baker JG; Hall IP; Hill SJ
Br J Pharmacol; 2002 Oct; 137(3):400-8. PubMed ID: 12237261
[TBL] [Abstract][Full Text] [Related]
4. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
5. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.
Baker JG; Proudman RG; Hill SJ
Mol Pharmacol; 2014 May; 85(5):811-29. PubMed ID: 24608857
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a secondary state of the human beta3-adrenoceptor.
Baker JG
Mol Pharmacol; 2005 Dec; 68(6):1645-55. PubMed ID: 16129733
[TBL] [Abstract][Full Text] [Related]
7. Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta1-adrenoceptor.
Baker JG; Proudman RG; Hawley NC; Fischer PM; Hill SJ
Mol Pharmacol; 2008 Nov; 74(5):1246-60. PubMed ID: 18687809
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of beta-adrenoceptor subtypes mediating relaxation in porcine isolated ureteral smooth muscle.
Wanajo I; Tomiyama Y; Yamazaki Y; Kojima M; Shibata N
J Urol; 2004 Sep; 172(3):1155-9. PubMed ID: 15311061
[TBL] [Abstract][Full Text] [Related]
9. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.
Baker JG; Proudman RG; Tate CG
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538
[TBL] [Abstract][Full Text] [Related]
10. beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.
Konkar AA; Zhai Y; Granneman JG
Mol Pharmacol; 2000 Feb; 57(2):252-8. PubMed ID: 10648634
[TBL] [Abstract][Full Text] [Related]
11. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP.
Gherbi K; Briddon SJ; Hill SJ
Br J Pharmacol; 2014 Dec; 171(23):5431-45. PubMed ID: 25052258
[TBL] [Abstract][Full Text] [Related]
12. Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay.
Wilson S; Chambers JK; Park JE; Ladurner A; Cronk DW; Chapman CG; Kallender H; Browne MJ; Murphy GJ; Young PW
J Pharmacol Exp Ther; 1996 Oct; 279(1):214-21. PubMed ID: 8858996
[TBL] [Abstract][Full Text] [Related]
13. In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.
Floreani M; Froldi G; Quintieri L; Varani K; Borea PA; Dorigo MT; Dorigo P
J Pharmacol Exp Ther; 2005 Dec; 315(3):1386-95. PubMed ID: 16160085
[TBL] [Abstract][Full Text] [Related]
14. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
15. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium.
Benschop RJ; Nijkamp FP; Ballieux RE; Heijnen CJ
Br J Pharmacol; 1994 Dec; 113(4):1311-6. PubMed ID: 7889286
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
17. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
Galindo-Tovar A; Vargas ML; Kaumann AJ
Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
[TBL] [Abstract][Full Text] [Related]
18. The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
Baker JG
Br J Pharmacol; 2010 Jul; 160(5):1048-61. PubMed ID: 20590599
[TBL] [Abstract][Full Text] [Related]
19. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats.
Godlewski G; Schlicker E; Baranowska U; Malinowska B
Shock; 2006 Nov; 26(5):510-5. PubMed ID: 17047523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
